Charming Medical vs Neuraxis
Charming Medical is the larger business, with $4.8m of revenue in fiscal 2026 against $3.6m for Neuraxis (1.3 times as much). Neuraxis grew faster (32.9% against -22.7%). Charming Medical kept more of each dollar of sales as profit: a net margin of -0.5% against -218.5%. Neuraxis carries less debt relative to equity (4.4% against 7.2%).
| Latest fiscal year | Charming MedicalMCTA, 2026 | NeuraxisNRXS, 2025 |
|---|---|---|
| Revenue | $4.8m | $3.6m |
| Revenue growth | -22.7% | 32.9% |
| Net income | −$22,648 | −$7.8m |
| Operating margin | -0.6% | -219.4% |
| Net margin | -0.5% | -218.5% |
| Return on equity | -0.9% | — |
| Free cash flow | −$1.6m | −$6.5m |
| Cash | $4.7m | $5.0m |
| Total debt | $371,598 | $148,293 |
| Debt to equity | 7.2% | 4.4% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | — | 24 |
| Market value | $474m | $83.3m |
| Price vs our value range | — | — |
| Moat score | — | — |
| Insider trades, 12 months | 0 buys, 0 sales | 9 buys, 0 sales |